Teachers Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $10.3M | Buy |
107,356
+232
| +0.2% | +$22.2K | 0.01% | 990 |
|
2018
Q4 | $7.59M | Hold |
107,124
| – | – | 0.01% | 1076 |
|
2018
Q3 | $9.16M | Buy |
107,124
+76,426
| +249% | +$6.53M | 0.01% | 1116 |
|
2018
Q2 | $3.56M | Buy |
30,698
+2,030
| +7% | +$235K | ﹤0.01% | 1612 |
|
2018
Q1 | $2.32M | Hold |
28,668
| – | – | ﹤0.01% | 1734 |
|
2017
Q4 | $1.68M | Buy |
28,668
+825
| +3% | +$48.4K | ﹤0.01% | 1956 |
|
2017
Q3 | $1.3M | Hold |
27,843
| – | – | ﹤0.01% | 2090 |
|
2017
Q2 | $1M | Buy |
27,843
+2,661
| +11% | +$95.8K | ﹤0.01% | 2234 |
|
2017
Q1 | $776K | Buy |
25,182
+700
| +3% | +$21.6K | ﹤0.01% | 2314 |
|
2016
Q4 | $820K | Buy |
24,482
+777
| +3% | +$26K | ﹤0.01% | 2282 |
|
2016
Q3 | $631K | Hold |
23,705
| – | – | ﹤0.01% | 2345 |
|
2016
Q2 | $523K | Sell |
23,705
-38
| -0.2% | -$838 | ﹤0.01% | 2383 |
|
2016
Q1 | $697K | Hold |
23,743
| – | – | ﹤0.01% | 2164 |
|
2015
Q4 | $784K | Hold |
23,743
| – | – | ﹤0.01% | 2151 |
|
2015
Q3 | $858K | Buy |
23,743
+550
| +2% | +$19.9K | ﹤0.01% | 2085 |
|
2015
Q2 | $1.04M | Buy |
23,193
+8,615
| +59% | +$387K | ﹤0.01% | 2093 |
|
2015
Q1 | $446K | Buy |
14,578
+438
| +3% | +$13.4K | ﹤0.01% | 2491 |
|
2014
Q4 | $719K | Hold |
14,140
| – | – | ﹤0.01% | 2223 |
|
2014
Q3 | $560K | Hold |
14,140
| – | – | ﹤0.01% | 2340 |
|
2014
Q2 | $609K | Buy |
14,140
+8,284
| +141% | +$357K | ﹤0.01% | 2329 |
|
2014
Q1 | $234K | Buy |
5,856
+1,290
| +28% | +$51.5K | ﹤0.01% | 2799 |
|
2013
Q4 | $125K | Hold |
4,566
| – | – | ﹤0.01% | 2993 |
|
2013
Q3 | $105K | Sell |
4,566
-28
| -0.6% | -$644 | ﹤0.01% | 2996 |
|
2013
Q2 | $81K | Buy |
+4,594
| New | +$81K | ﹤0.01% | 3011 |
|